
    
      The present phase IV study is a randomised, double-blind, placebo and active-controlled,
      parallel group study in moderate to severe acute pain after removal of impacted lower third
      molar.

      In this single-dose clinical trial patients are randomized to the following 3 treatment arms
      in a 2:2:1 ratio:

        -  TRAM.HCL/DKP.TRIS

        -  Paracetamol/TRAM.HCL

        -  Placebo.
    
  